DNA & Genetics Novartis, UNP, Launch Up-to-$1.8B+ Macrocyclic Peptide PartnershipBy adminFebruary 18, 20260 Novartis will apply Unnatural Products (UNP)’s artificial intelligence (AI)-guided macrocyclic peptide platform to develop next-generation cardiovascular disease therapeutics, through a…
DNA & Genetics Novartis Plans to Build Flagship Manufacturing Hub in North CarolinaBy adminNovember 21, 20250 Credit: Tom Werner/Getty Images Officials at Novartis report that the company plans to expand its operations in North Carolina, creating…
DNA & Genetics Novartis Inks Up-to-$5.7B Second Collaboration with Monte RosaBy adminSeptember 17, 20250 Nearly a year after licensing Monte Rosa Therapeutics’ Phase II-bound autoimmune disease candidate MRT-6160, Novartis has agreed to partner on…
